Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in

François-Pantaléon Musungayi Kajingulu1, François Bompeka Lepira1, Aliocha Natuhoyila Nkodila2

  • 1Department of Internal Medicine, Division of Nephrology-Dialysis, University of Kinshasa Hospital, Kinshasa, Democratic Republic of the Congo.

Insights

In Black African hemodialysis patients, elevated proprotein convertase subtilisin/kexin type 9 (PCSK9) is linked to dyslipidemia and a higher risk of cardiovascular events, independent of other factors.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Biochemistry

Background:

  • Cardiovascular diseases (CVDs) are a primary cause of mortality.
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) is implicated in lipid homeostasis and may serve as a biomarker.
  • Understanding PCSK9's role in dyslipidemia and CVD risk is crucial, especially in specific populations.

Purpose of the Study:

  • To investigate the association between serum PCSK9 levels, dyslipidemia, and the future risk of cardiovascular events.
  • To evaluate PCSK9 as a potential biomarker in Black African patients with chronic kidney disease (CKD G5).

Main Methods:

  • A cross-sectional study involving 251 CKD G5 hemodialysis patients in Kinshasa, DRC.
  • Serum PCSK9 and lipid profiles (TC, LDL-c, HDL-c, TG) were measured.
  • The Framingham predictive instrument was used to assess cardiovascular event risk.

Main Results:

  • Higher PCSK9 levels correlated positively with TC, LDL-c, and TG, and negatively with HDL-c.
  • PCSK9, smoking, overweight, and atherogenic dyslipidemia were associated with future cardiovascular events.
  • Elevated PCSK9 levels independently predicted an increased risk of cardiovascular events in this population.

Conclusions:

  • Increased serum PCSK9 is associated with adverse lipid profiles in Black African hemodialysis patients.
  • Serum PCSK9 levels are a significant independent predictor of cardiovascular events in this cohort.
  • PCSK9 may be a valuable biomarker for assessing cardiovascular risk in CKD patients of African descent.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
275
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
451
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
218